These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12058792)

  • 1. Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men.
    Agewall S; Fagerberg B
    Clin Cardiol; 2002 Jun; 25(6):287-90. PubMed ID: 12058792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Arveiler D; Ferrieres J; Evans A; Amouyel P; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2002 Aug; 163(2):377-84. PubMed ID: 12052486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men.
    Assmann G; Schulte H; von Eckardstein A
    Am J Cardiol; 1996 Jun; 77(14):1179-84. PubMed ID: 8651092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long-Term Follow-up Study on Real-World Patients Receiving Percutaneous Coronary Intervention.
    Liu HH; Cao YX; Jin JL; Zhang HW; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Xu RX; Chen XH; Li JJ
    J Am Heart Assoc; 2020 Feb; 9(3):e014581. PubMed ID: 32013705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Luc G; Bard JM; Ferrières J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetière P
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1155-61. PubMed ID: 12117731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
    Schaefer EJ; Lamon-Fava S; Jenner JL; McNamara JR; Ordovas JM; Davis CE; Abolafia JM; Lippel K; Levy RI
    JAMA; 1994 Apr; 271(13):999-1003. PubMed ID: 8139085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.
    Bostom AG; Cupples LA; Jenner JL; Ordovas JM; Seman LJ; Wilson PW; Schaefer EJ; Castelli WP
    JAMA; 1996 Aug; 276(7):544-8. PubMed ID: 8709403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study.
    Boutouyrie P; Tropeano AI; Asmar R; Gautier I; Benetos A; Lacolley P; Laurent S
    Hypertension; 2002 Jan; 39(1):10-5. PubMed ID: 11799071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients.
    Torremocha F; Hadjadj S; Carrié F; Rosenberg T; Herpin D; Maréchaud R
    Diabetes Metab; 2001 Feb; 27(1):49-57. PubMed ID: 11240446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men.
    Agewall S; Wikstrand J; Fagerberg B
    J Hypertens; 1998 Apr; 16(4):537-41. PubMed ID: 9797200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease.
    Kugiyama K; Doi H; Takazoe K; Kawano H; Soejima H; Mizuno Y; Tsunoda R; Sakamoto T; Nakano T; Nakajima K; Ogawa H; Sugiyama S; Yoshimura M; Yasue H
    Circulation; 1999 Jun; 99(22):2858-60. PubMed ID: 10359727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men.
    Seed M; Ayres KL; Humphries SE; Miller GJ
    Am J Med; 2001 Jan; 110(1):22-7. PubMed ID: 11152861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis.
    Saleheen D; Haycock PC; Zhao W; Rasheed A; Taleb A; Imran A; Abbas S; Majeed F; Akhtar S; Qamar N; Zaman KS; Yaqoob Z; Saghir T; Rizvi SNH; Memon A; Mallick NH; Ishaq M; Rasheed SZ; Memon FU; Mahmood K; Ahmed N; Frossard P; Tsimikas S; Witztum JL; Marcovina S; Sandhu M; Rader DJ; Danesh J
    Lancet Diabetes Endocrinol; 2017 Jul; 5(7):524-533. PubMed ID: 28408323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: a prospective analysis from the Finnmark Study.
    Njølstad I; Arnesen E
    Arch Intern Med; 1998 Jun; 158(12):1326-32. PubMed ID: 9645827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease.
    Fukushima H; Kugiyama K; Sugiyama S; Honda O; Koide S; Nakamura S; Kawano H; Soejima H; Miyamoto S; Yoshimura M; Sakamoto T; Ogawa H
    Am J Cardiol; 2001 Dec; 88(12):1370-3. PubMed ID: 11741554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease.
    Suzuki T; Futami-Suda S; Igari Y; Watanabe K; Ouchi M; Suzuki K; Sekimizu K; Kigawa Y; Nakano H; Oba K
    Lipids Health Dis; 2013 Mar; 12():31. PubMed ID: 23496967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
    Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
    Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Lipoprotein(a) Levels as a Predictor of Major Adverse Cardiovascular Events in Hospitalized-Acute Myocardial Infarction Patients.
    Sumarjaya IDGD; Nadha IKB; Lestari AAW
    Vasc Health Risk Manag; 2020; 16():125-132. PubMed ID: 32308405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.